Sitemap | Medicalalgorithms.com

Model of Tham et al for Determining the Daily Dose of Warfarin to Give to an Asian Based on Genotypic Analysis of Vitamin K Eposoxide Reductase Complex and Cytochrome P450 2C9

Models of Sconce et al for Determining the Daily Dose of Warfarin to Give That Include Genotypic Analysis of CYP2C9 and VKORC1

Model of Kamali et al for Determining Warfarin Dose in a Patient Based on CYP2C9 Genotype

Warfarin (Coumadin) Resistance

Model of Zhu et al for Determining a Patient's Daily Dose Requirement for Warfarin

Parenteral Administration of Warfarin

Risk Factors of Hylek et al for Excessive Warfarin Anticoagulation

Algorithm of Dunn for the Perioperative Management of a Patient Receiving Oral Anticoagulation

Antithrombotic Therapy for a Patient with a Mechanical Heart Valve

Antithrombotic Therapy for a Patient with a Prosthetic Heart Valve

Warfarin Resistance Associated with Poor Intestinal Absorption

Prophylactic Oral Therapy with Dabigatran Following Hip or Knee Arthroplasty

Prophylactic Oral Therapy with Rivaroxaban Following Hip or Knee

Regression Model of Wells et al for Predicting Warfarin Dose Using Pharmacogenetics

International Normalized Ratio (INR)

Estimating the Percent Prothrombin Complex Activity from the INR

Indications for Using an Alternative Method to the PT or INR for Monitoring Warfarin Therapy in a Patient with a Lupus Anticoagulant

PT, INR and aPTT in a Patient Receiving Both Heparin and Warfarin

Adjusting the Amount of Specimen Anticoagulant for an Elevated Hematocrit

Activated Protein C (APC) Resistance Ratio

Protein S and C Levels in Patients Receiving Coumadin Therapy

Neonatal Purpura Fulminans Associated with Congenital Protein C Deficiency

Conditions Associated with Acquired Deficiency of Protein S and/or Protein C

Beta-Thromboglobulin to Platelet Factor 4 Ratio

Criteria of Ginsberg for the Probability of Deep Vein Thrombosis

Screening Tests for Exclusion of Deep Vein Thrombosis

Risk of Deep Vein Thrombosis and Pulmonary Embolism in a Surgical Patient

Risk Factor Score of Weiss and Bernstein for Venous Thromboembolism in Obstetric Patients

Indications for Placement of an Inferior Vena Cava Filter in a Patient with Deep Vein Thrombosis

Clinical Prediction Index of Kahn et al for Deep Vein Thrombosis in Patients with Leg Symptoms

Risk Assessment Profile (RAP) of Greenfield et al for Venous Thromboembolism in Adult Trauma Patients

Indications for Prophylactic Placement of an Inferior Vena Cava Filter in a Trauma Patient

Discriminant Formula of Clayton et al for Prediction of Post-Operative Deep Vein Thrombosis

Factors Justifying an Extensive Evaluation in a Patient with Idiopathic Deep Vein Thrombosis

Pseudothrombophlebitis Associated with a Baker's Cyst

Reporting Standards of the International Consensus Committee on Chronic Venous Disease for Risk of Acute Lower Extremity Thrombosis

Reporting Standards of the International Consensus Committee on Chronic Venous Disease for Describe the Extent of Thrombosis in a Lower Extremity

Modification of Cafferata et al to the Reporting Standards of the ICS on CVT for Risk of Acute Lower Extremity Thrombosis Associated with Trauma

Duration of Therapy for a Patient with Deep Vein Thrombosis

Exclusion Criteria for Home (Outpatient) Therapy of Acute Deep Vein Thrombosis

Algorithm of Gorman et al for the Investigation of Deep Vein Thrombosis

Diagnosis of Thrombosis of the Axillary and Subclavian Veins

Diagnosis of Paget-von Schroetter Syndrome with Axillosubclavian Venous Thrombosis (Exertional Thrombosis, Venous Type Thoracic Outlet Obstruction)

Algorithm of Knudson et al for Venous Thromboembolism Prophylaxis in a Trauma Patient

Risk Factors of Vavilala et al for Venous Thromboembolism in Pediatric Trauma Patients

Predictors of Goldenberg et al for a Poor Outcome in a Child with Thrombosis

Clinical Findings Associated with Severe Deep Vein Thrombosis in a Lower Extremity (Phlegmasia and Venous Gangrene)

Risk Factors of Cook et al for Deep Vein Thrombosis in a Patient in the Intensive Care Unit (ICU)

Predictors of Iskander et al for Propagation of Deep Vein Thrombosis Above the Knee in a Trauma Patient

Risk Factors of Hansson et al for Recurrent Deep Vein Thrombosis

Risk Assessment Scorecard of Lutz et al for Venous Thromboembolism

Scoring System of Bjorgell and Robertson for Grading the Extent of Deep Leg Vein Thrombosis

Venographic Classification of Marder et al for Quantifying Venous Thrombosis in a Leg

Venographic Classification of Marder et al for Quantifying Venous Thrombosis in an Arm

Venographic Classification of Arnesen et al for Quantifying Venous Thrombosis in a Leg

Swelling to Pain (S/P) Ratio of Lundh and Fagher for Evaluating a Patient for a Deep Vein Thrombosis in the Lower Leg

Risk Score of Rogers et al for Predicting Venous Thromboembolism in a General or Vascular Surgery Patient Based on the Patient Safety in Surgery Study

Clinical Features of Mondor's Disease (Thrombophlebitis in a Subcutaneous Vein of the Breast)

Risk Factors for Deep Vein Thrombosis in an HIV-Positive Patient

Risk Factors of Adams et al for Thromboembolic Disease in a Patient Following Trauma

Protocol of Adams et al for Prevention of Thromboembolic Disease in a Patient After Major Trauma

Risk Factors of Marik and Plante for Venous Thromboembolism Following Cesarean Section

Clinical Rule of Toll et al for Ruling Out Deep Vein Thrombosis of the Leg in Primary Care

Risk Score of Lindqvist et al for Postpartum Thromboembolism

Thrombosis and JAK2 Mutation Status

Risk Factors of Rubin-Asher et al for Failure of Heparin Thromboprophylaxis in a Patient with Acute Traumatic Spinal Cord Injury

Model of Spyropoulos et al for Identifying a Hospitalized Medical Patient at Risk for Venous Thromboembolism on Admission

IMPACTILL Model of Spyropoulos et al for Identifying a Hospitalized Medical Patient at Risk for Venous Thromboembolism

American College of Physicians (ACP) Guidelines for Venous Thromboembolism (VTE) Prophylaxis in a Hospitalized Medical Patient

Risk Factors of Mantilla et al for Clinical Relevant Thromboemboli in a Patient Undergoing Knee or Hip Arthroplasty

Risk Factors of Scarborough et al for Venous Thromboembolism Following Aortic Surgery

Clinical Features of Superficial Thrombophlebitis and Superficial Migratory Thrombophlebitis

Paradoxical Thrombosis

Classification of Simonneau et al for Anticoagulation-related Bleeding

Risk Score of Landefeld et al for Anticoagulant-related Major Bleeding in Hospitalized Patients

Utrecht Bleeding Risk Score During Treatment of Acute Venous Thromboembolism

Risk Factors for Bleeding During Warfarin Therapy

Risk Score of Kuijer et al for Bleeding During Anticoagulant Treatment for Venous Thromboembolism

Contraindications to Anticoagulant Therapy

Bleeding Risk Indices of van der Meer et al

Risk Score of Landefeld and Goldman for Warfarin-Associated Major Bleeding in Outpatients

The Bleeding Severity Index of Landefeld et al for Bleeding Caused by Medical Therapy

Risk Factors of Walker and Jick for Bleeding During Heparin Therapy

Clinical Features of a Retroperitoneal Hematoma in an Anticoagulated Patient

Risk Factors of Alexander et al for an Excessive Dose of a Glycoprotein IIb/IIIa Inhibitor with Bleeding During the Treatment of Non-ST Segment Elevation Acute Coronary Event

Criteria of Graafsma et al for Anticoagulant-Related Bleeding with a Bleeding Severity Index

The Outpatient Bleeding Risk Index of Beyth et al

Criteria of Montalescot et al for Major and Minor Bleeding During Heparin Therapy (STEEPLE Criteria)

Bleeding Risk Model of Shireman et al for an Elderly Patient Being Treated with Warfarin

BleedScore of Serebruany and Atar for Classifying Bleeding Events

Risk Score of Mehran et al for Bleeding in a Patient Receiving Antithrombotic Therapy for the Acute Coronary Syndrome (ACS)

CRUSADE Bleeding Score for Predicting Major In-Hospital Bleeding in a Patient Being Treated for Non-ST-Segment Elevation Myocardial Infarction

Risk Factors of Manoukian et al for Major Bleeding in a Patient with an Acute Coronary Syndrome in the ACUITY Trial

HAS-BLED Score for Predicting the Risk of Major Bleeding in a Patient with Atrial Fibrillation

HEMORR2HAGES Score of Gage et al for Predicting Hemorrhage in a Patient with Atrial Fibrillation

Risk Factors for Bleeding During Antithrombotic Therapy from the NICE Guidelines for Atrial Fibrillation

Risk Score of Ducrocq et al for Serious Bleeding in a Patient at Risk for Atherothrombosis (REACH Score)

Evaluating a Patient for Abnormal Bleeding from an Occult Malignancy Associated with Anticoagulant or Antithrombotic Therapy

Bleeding Academic Research Consortium (BARC) Classification of Bleeding

Antithrombin III Replacement Therapy

Indications for Measuring Antithrombin III Levels

Predicting Survival in Thrombotic Thrombocytopenia Purpura with Laboratory Tests

Clinical Severity Scoring System of Rose and Eldor for TTP or HUS

Prognostic Factors of Pereira et al in Thrombotic Thrombocytopenic Purpura and the Hemolytic Uremic Syndrome

Deficiency in ADAMTS13 and Thrombotic Thrombocytopenic Purpura

Recurrent or Familial Hemolytic-Uremic Syndrome or Membranoproliferative Glomerulonephritis in Factor H Deficiency

Criteria of Tuncer et al for Clinical Outcome After Treating a Patient with TTP-HUS

Modified Rose Index of the Canadian Apheresis Group for TTP or HUS

Index of Wyllie et al for Predicting Mortality in a Patient with TTP or HUS

Risk Factors of Oakes et al for Mortality in a Pediatric Patient with Postdiarrheal Hemolytic Uremic Syndrome

HIV-Related Thrombotic Thrombocytopenic Purpura (TTP) and Hemolytic Uremic Syndrome (HUS)

Clinical Features of the Atypical Hemolytic-Uremic Syndrome

Criteria of Zhan et al for Therapeutic Response in a Patient with Thrombotic Thrombocytopenic Purpura (TTP)

Conditions Associated with Thrombotic Thrombocytopenic Purpura (TTP)

Use of the Platelet Count and Prothrombin Time to Separate TTP-HUS from DIC

Clinical Prediction Score of Bentley et al for Thrombotic Thrombocytopenia Purpura (TTP)

Classification and Regression Tree (CART) of Bentley et al to Identify a Patient with Low ADAMTS13

Algorithm of Caramazza et al for Management of a Patient with TTP-HUS

Congenital Thrombotic Thrombocytopenic Purpura (TTP)

Clinical Features of Upshaw-Schulman Syndrome (USS)

Initial Evaluation of a Patient with Thrombotic Thrombocytopenic Purpura (TTP)

Neonatal Hemolytic Uremic Syndrome (HUS) Associated with Cobalamin C Disease

Hemolytic Uremic Syndrome (HUS) in Children Associated with Invasive Streptococcus pneumoniae (Streptococcus pneumoniae-Associated Hemolytic Uremic Syndrome, SP-HUS)

Risk Factors of Peigne et al for Death in a Patient with a Thrombotic Microangiopathy

Laboratory Diagnosis of Antiphospholipid Syndromes

Clinical Syndromes Associated with Anticardiolipin Antibodies

Evaluation of a Patient with a Lupus Anticoagulant and a Prolonged Prothrombin Time (Hypoprothrombinemia-Lupus Anticoagulant Syndrome)

Catastrophic Antiphospholipid Syndrome (CAP, Asherson Syndrome)

Features of Antiphospholipid Antibody-Associated Cardiac Valve Disease

Features of Antiphospholipid Antibody-Associated Nephropathy

Features of Antiphospholipid Antibody-Associated Livedo Reticularis

Features of Antiphospholipid Antibody-Associated Thrombocytopenia

Sneddon Syndrome (Livedo Reticularis and Ischemic Cerebrovascular Disease) Associated with Antiphospholipid Antibodies

Updated International Consensus Criteria for the Diagnosis of the Antiphospholipid Syndrome (Sydney Criteria)

Risk Factors of Tarr et al for Thrombosis in a Lupus Patient with Antiphospholipid Antibodies

Reasons to Suspect the Antiphospholipid Antibody Syndrome in a Patient with a Disorder Resembling Multiple Sclerosis (MS)

Score of Goel et al for Familial Antiphospholipid Antibody Syndrome: Clinical Subscore

Score of Goel et al for Familial Antiphospholipid Antibody Syndrome: Laboratory Subscores

Score of Goel et al for Familial Antiphospholipid Antibody Syndrome: Evaluation of the Patient and Family

Risk Factors for Thrombosis in a Patient with Systemic Lupus Erythematosus (SLE)

Lupus Anticoagulant-Hypoprothrombinemia Syndrome (LAHPS)

Criteria of Asherson et al for the Catastrophic Antiphospholipid Syndrome (CAPS)

Lupus Anticoagulant Sensitivity Index (LASI)

Conditions Associated with the Lupus Anticoagulant

Sticky Platelet Syndrome

Indications to Evaluate a Patient for Hypercoagulability (Thrombophilia)

Heparin-Induced Thrombocytopenia Types I and II

Score of Pouplard et al for Estimating the Likelihood of Heparin-Induced Thrombocytopenia

Testing Algorithm for the Diagnosis of Heparin-Induced Thrombocytopenia

Therapy for Heparin-Induced Thrombocytopenia with Lepirudin (Refludan) in a Patient with Normal Renal Function

Therapy for Heparin-Induced Thrombocytopenia with Lepirudin (Refludan) in a Patient with Renal Insufficiency

Scoring System of Chong and Chong for Diagnosis of Heparin-Induced Thrombocytopenia (HIT)

Acute Systemic Reaction Following Administration of Intravenous Heparin

Conditions That May Mimic Heparin-Induced Thrombocytopenia (Pseudo-HIT)

Score of Warkentin and Heddle for the Diagnosis of Heparin-Induced Thrombocytopenia (HIT)

White Clot Syndrome in Heparin-Induced Thrombocytopenia (HIT)

Skin Lesions at Subcutaneous Heparin Injection Sites in a Patient with Heparin-Induced Thrombocytopenia (HIT)

Acute Adrenal Hemorrhage in a Patient with Heparin-Induced Thrombocytopenia (HIT)

Delayed-Onset Heparin-Induced Thrombocytopenia

Risk Factors of Elalamy et al for an Unfavorable Clinical Outcome in Patients with Heparin-Induced Thrombocytopenia (HIT)

Simple Scoring System of Messmore et al for Early Management of Heparin-Induced Thrombocytopenia (HIT)

DIC Score of Bick

Monitoring Therapy for DIC with the DIC Score

DIC Score of Yu et al

DIC Scoring Algorithm of the ISTH Scientific and Standardization Committee

Kasabach-Merritt Phenomenon and Vascular Tumors in Children

Risk Factors for Disseminated Intravascular Coagulation (DIC) in a Trauma Patients

Criteria of the ISTH Scientific and Standardization Committee for Non-Overt DIC

The New Japanese Diagnostic Criteria for Disseminated Intravascular Coagulation in Critically Ill Patients (Japanese Association of Acute Medicine or JAAM Criteria)

Criteria of Shirahata et al for Disseminated Intravascular Coagulation (DIC) in a Newborn Infant

Criteria of Kobayashi et al for Disseminated Intravascular Coagulation (Japanese Diagnostic Criteria, Japanese Ministry of Health and Welfare, JMHW)

Classification of Disseminated Intravascular Coagulation (DIC) Based on the Degree of Compensation in the Production of Coagulation Factors and Platelets

Evolving DIC Score of Kinasewitz et al in a Septic Patient

Consumptive Coagulopathy in a Patient with a Large Venous Malformation

Contraindications to Thrombolytic Therapy

Bleeding Risk after Contemporary Thrombolytic Therapy Following Myocardial Infarction

Thrombolytic Predictive Instrument of Selker et al for Intracranial Hemorrhage

Thrombolytic Predictive Instrument of Selker et al for Major Bleeding

Dosing an Infusion of Abbokinase Brand Urokinase for a Patient with Pulmonary Embolism

Determining the Dose of Alteplase for Thrombolysis in Acute Stroke

Determining the Accelerated Infusion Dose of Alteplase for Thrombolysis in Acute Myocardial Infarction

Determining the Dose of Alteplase for a 3 Hour Infusion After Acute Myocardial Infarction

Model of Sloan et al for Risk of 30-Day Mortality Associated with Intracranial Hemorrhage Associated with Thrombolysis Therapy After Acute Myocardial Infarction

Contraindications (Exclusion Criteria) of Wechsler for Intravenous Tissue Plasminogen Activator (t-PA) Therapy Following Acute Ischemic Stroke

Guidelines of Thomson et al for Anticoagulant Therapy to Prevent Stroke in Patients with Atrial Fibrillation

Prophylactic Therapy to Reduce the Risk of Stroke in Patients with Atrial Fibrillation

Algorithm of Hardman and Cowie for Anticoagulation Therapy in Non-Rheumatic Atrial Fibrillation

Rule of van Walraven et al for Using Aspirin as Stroke Prophylaxis in Patients with Non-Valvular Atrial Fibrillation

Clinical Staging of Immune Thrombocytopenic Purpura

Classification of Holt for the Response to Therapy in a Child with Immune Thrombocytopenic Purpura (ITP)

Risk Factors of Schattner and Bussel for Mortality in Immune Thrombocytopenic Purpura (ITP)

Criteria of Stasi et al for Response to Therapy for Immune Thrombocytopenic Purpura (ITP)

Criteria of Blanchette et al for Bleeding Severity in a Child with Acute Idiopathic Thrombocytopenic Purpura (ITP)

Criteria of Bolton-Maggs and Moon for Bleeding Severity in a Child with Acute Idiopathic Thrombocytopenic Purpura (ITP)

Grading Criteria of Buchanan and Adix for Hemorrhage in a Child with Acute Idiopathic Thrombocytopenic Purpura (ITP)

Criteria of Medeiros and Buchanan for Major Hemorrhage in a Child with Acute Idiopathic Thrombocytopenic Purpura (ITP)

Outcomes of Portielje et al for an Adult with Idiopathic Thrombocytopenic Purpura

Criteria of Lacey and Penner for Idiopathic Thrombocytopenic Purpura (ITP) in the Adult

Bleeding Score of Godeau et al for a Patient with Autoimmune Thrombocytopenic Purpura

Bleeding Score of Khellaf et al for a Patient with Autoimmune Thrombocytopenic Purpura

Recommendations of Stasi and Provan for Emergency Treatment of a Patient wtih Immune Thrombocytopenic Purpura

Immune Thrombocytopenia Associated with Helicobacter pylori Gastritis

The Post-Thrombotic Score (PTS) of Brandjes et al

The Post-Thrombotic Score (PTS) of Villalta et al

Criteria of Goldenberg et al for the Post-Thrombotic Syndrome in a Child

Clinical Features of Upper Extremity Post-Thrombotic Syndrome

Criteria for Superwarfarin-induced Coagulopathy

Factitious Bleeding Disorder Associated with Self-Administration of Warfarin

Criteria for Acquired von Willebrand's Disease

Types of von Willebrand's Disease Based on Laboratory Test Findings

Criteria of the Hospital for Sick Children for Significant Mucocutaneous Bleeding in a Patient with von Willebrand's Disease

Criteria of the International Society on Thrombosis and Haemostasis (ISTH) for Significant Mucocutaneous Bleeding in a Patient with von Willebrand's Disease

Desmopressin Test Dose in a Patient with von Willebrand's Disease

Bleeding Score of Tosetto et al for a Patient with von Willebrand's Disease

Acquired von Willebrand's Disease with Bleeding in a Patient with Essential Thrombocythemia

Classification of Michiels et al for Acquired von Willebrand Syndrome (AvWS)

Pseudo von Willebrand Disease (Platelet Type or PT von Willebrand Disease)

Evaluation of PT and aPTT Test Results

Using Factor V and VII Levels in the Evaluation of the Bleeding Patient

Correction of the Whole Blood Fibrinogen for Hematocrit and Correlation with Plasma Fibrinogen

Use of Vitamin K to Reverse Warfarin-Associated Coagulopathy

Use of Prothrombin Complex Concentrate to Reverse the Effects of a Vitamin K Antagonist

Use of Fresh Frozen Plasma (FFP) to Reverse the Effects of a Vitamin K Antagonist

Protocol of Goodnough et al for Reversal of a Prolonged INR with Recombinant Factor VIIa (rFVIIa)

Therapeutic Options for a Patient with Uremic Bleeding

Clinical Features of Uremic Bleeding

Bleeding Risk Index of Elting et al in Patients with Malignant Lymphoma or Solid Tumors

Deep Vein Thrombosis Associated with Carcinoma (Trousseau's Syndrome)

Risk Factors of Blom et al for Venous Thrombosis in a Patient with a Malignancy

Risk Factors of Khorana et al for Venous Thromboembolism in a Patient with Cancer Starting Chemotherapy

Risk Factors of Khorana et al for Thromboembolism in a Hospitalized Cancer Patient with Neutropenia

Algorithm of Gerber et al for Managing a Patient with Venous Thromboembolism and a Primary or Metastatic Brain Tumor

Risk Factors of Bohlius et al for Thrombosis Associated with Recombinant Human Erythropoietin Therapy in a Patient with Cancer

Risk Factors of Chew et al for Venous Thromboembolism in a Woman with Breast Cancer

Risk Factors of Tesselaar and Osanto for Venous Thromboembolism in a Patient with Lung Cancer

Risk Score of Kim et al for Fatal Intracranial Hemorrhage in a Patient with Acute Leukemia

Risk Factors of Lyman et al for Venous Thromboembolism in a Patient with a Malignant Disease

Acquired von Willebrand's Syndrome (AVWS) in a Child with Wilm's Tumor

Risk Score of Khorana et al for Chemotherapy-Associated Thrombosis

Risk Score of Ay et al for Venous Thromboembolism in a Patient with Cancer (Expanded Khorana Score)

Soluble P-Selectin and Other Risk Factors of Ay et al for Venous Thromboembolism in a Patient with Cancer

Risk Factors for Thromboembolism in a Patient with Multiple Myeloma

Risk Factors of Anaissie et al for Venous Thromboembolism in a Patient with Multiple Myeloma

Risk Factors of Yokoyama et al for Venous Thromboembolism in a Japanese Patient with Diffuse Large B-Cell Lymphoma

Bleeding Severity Measurement Scale (BSMS) of Webert et al for a Patient with Chemotherapy-Induced Thrombocytopenia

Contraindications to the Use of Recombinant Protein C

Algorithm of Cunningham et al for Laboratory Testing in a Patient with Suspected Dysfibrinogenemia

Clinical and Laboratory Features of Congenital Afibrinogenemia or Hypofibrinogenemia

Clinical and Laboratory Features of Congenital Dysfibrinogenemia

Clinical and Laboratory Features of Fibrinogen Brescia (Familial Hypofibrinogenemia with Hepatocytic Inclusion Bodies)

Classification of Medicina et al for Hereditary Disorders of Fibrinogen Associated with Hepatocytic Inclusion Bodies

Risk Factors of Oh et al for Early and Late Hepatic Artery Thrombosis After Liver Transplantation

Risk Factors of Vivarelli et al for Hepatic Artery Thrombosis or Stenosis After Liver Transplantation

Aspirin Resistance

Contraindications to Aspirin Therapy

Recommendations of the French Society of Anesthesiology and Intensive Care (SFAR) for Administration of Antiplatelet Agents in the Perioperative Period

Treatment of a Bleeding Patient with Liver Failure

Hemostatic Defects in a Patient with End-Stage Liver Disease

Protocol of Poetzsch and Madlener for Anticoagulation During Cardiopulmonary Bypass Using Danaparoid Sodium

Protocol of Poetzsch and Madlener for Anticoagulation During Cardiopulmonary Bypass Using Lepirudin (r-Hirudin)

Reversal of Unfractionated Heparin Therapy with Protamine Sulfate

Patients to Screen for Allergy to Protamine Sulfate

Types of Adverse Reactions Following Administration of Protamine Sulfate

Reversal of Dalteparin Sodium Overdosage with Protamine Sulfate

Protocol of Hirsh and Raschke for the Reversal of Antithrombotic Effect of Low Molecular Weight Heparin (LMWH) Using Protamine Sulfate

Protocol of Cole et al for Use of Aprotinin in Children Undergoing Spinal Surgery

Prophylactic Dosage Regimens of Dalteparin Sodium for Hip Replacement Surgery

Antenatal Thromboembolic Prophylaxis with Low Molecular Weight (LMW) Heparin

Dosing Low Molecular Weight (LMW) Heparin for the Treatment of Venous Thromboembolism in Early Pregnancy

Weight-Based Dosing Equation of Rondina et al for Thromboprophylaxis in a Morbidly Obese Patient

Risk Factors of DeVeber et al for Cerebral Sinovenous Thrombosis in Children

Clinical Findings in a Patient with a Cerebral Sinus Thrombosis

Risk Factors of Starn for Thrombosis of a Cerebral Vein or Sinus

Risk Factors of Hanes et al for Thrombocytopenia in a Trauma Patient in the Intensive Care Unit (ICU)

Risk Factors of Ferrara et al for Coagulopathy and Death Following Massive Transfusion for Trauma

Criteria of Talving et al for Coagulopathy Associated with Traumatic Brain Injury (TBI)

Risk Factors of Talving et al for Traumatic Brain Injury (TBI) Associated Coagulopathy

Conditions Associated with Systemic Fibrinolysis

Features of a Hereditary Deficiency of Alpha-2 Antiplasmin

Plasminogen Activator Inhibitor (PAI) Concentration and Genotype

Congenital Plasminogen Deficiency Type I with Ligneous Conjunctivitis

Effects on Coagulation Associated with Herbal or Dietary Supplements

Inhibitory Effect of Chocolate and Cocoa on Platelet Aggregation

Foods Rich in Polyphenols and Flavonoids

Thrombosis Risk Associated with Intravenous Immune Globulin Therapy

Models of Holland and Brooks for Predicting the Impact of Fresh Frozen Plasma (FFP) Transfusion on the INR

Calculating Amount of Factor Replacement

Increment in Coagulation Factor after Transfusion

Factor VIII-vWF Dosage Recommendations of Mannucci for a Patient with von Willebrand's Disease

Estimating the Peak Factor VIII Coagulant Activity Needed When Treating a Patient with von Willebrand's Disease

Therapy with Recombinant Factor VIIa in a Patient with a Factor VIII or IX Inhibitor

Risk Factors Associated with Thrombosis Following Recombinant Factor VIIa Therapy

Use of Recombinant Factor VIIa in a Patient with Congenital Factor VII Deficiency

Therapy with Recombinant Factor VIIa for Uncontrollable Hemorrhage in a Patient with a Qualitative or Quantitative Platelet Disorder

Therapy with Recombinant Factor VIIa for Uncontrollable Hemorrhage in a Patient with Liver Disease, Trauma or Recent Surgery

Therapy with Recombinant Factor VIIa for Control of Massive Pulmonary Hemorrhage

Factors of Knudson et al Associated with Poor Response to Recombinant Factor VIIa in a Trauma Patient

Criteria of George et al for the Diagnosis of Drug-Induced Thrombocytopenia

Algorithm of Berkowitz et al for Thrombocytopenia Following Infusion of Abciximab (c7E3 Fab)

Differential Diagnosis of Thrombocytopenia in an HIV-Positive Patient

Screening Tool of Philipp et al for a Bleeding Disorder in a Woman with Menorrhagia

Criteria of Federle et al for Distinguishing Abdominal Bleeding Due to Coagulopathy from a Ruptured Abdominal Aortic Aneurysm on CT Scan

Differential Diagnosis of Bleeding in a Patient with Normal PT and aPTT

Ovarian Bleeding in a Woman with a Congenital Bleeding Disorder

Heparin-Related Bleeding in a Patient with a Mast Cell Disorder

Risk Factors for Epinephrine Intoxication Following Injection or Topical Application

Clinical Findings of Epinephrine Intoxication Following Injection or Topical Application As a Hemostatic Agent

Causes of Spontaneous Retroperitoneal Hemorrhage

Lenk's Triad and Other Signs and Symptoms of Spontaneous Retroperitoneal Hemorrhage

Wunderlich's Syndrome (Spontaneous Retroperitoneal Hemorrhage From One or Both Kidneys)

Clinical and Laboratory Features of Neonatal Isoimmune Thrombocytopenia

Clinical Features of Hemorrhagic Disease of the Newborn (HDNB)

Risk Factors for Vitamin K Deficiency Bleeding (VKDB) in an Infant

Classification of Hemorrhagic Disease of the Newborn (HDNB) Based on Time of Clinical Onset

Differential Diagnosis of Hemorrhagic Disease of the Newborn (HDNB)

Intravenous Therapy with Tranexamic Acid in Severe Trauma

Use of RICE as Adjunctive Management of Hemorrhage in a Patient with Hemophilia

Factors Affecting the Safety of Prophylactic Anticoagulant Therapy of a Patient at Risk for Venous Thromboembolism

Peds-Clot Clinical Decision Rule of Sharathkumar et al

Score of Kucher et al for the Risk of Venous Thrombembolism (VTE) in a Hospitalized Patient

Padua Prediction Score (PPS) for Risk of Venous Thrombembolism (VTE) in a Hospitalized Patient

Caprini Risk Model for Venous Thromboembolism

Risk Factors of Doepker et al for Bleeding in a Patient in the ICU Anticoagulated with Argatroban

Hypercoagulability in Patient with Thalassemia

Dosing Argatroban for a Patient with Heparin-Induced Thrombocytopenia (HIT)

Equations of Schlimp et al for Predicting Plasma Fibrinogen in the Emergency Room Following Major Trauma

Algorithm of Stern et al for Anticoagulating a Patient with Chronic Atrial Fibrillation

Flowchart of Lip et al for Using an Oral Anticoagulant to Prevent Stroke in a Patient with Atrial Fibrillation

Predictors of Hart et al for Ischemic Stroke in a Patient Receiving Aspirin Therapy for Atrial Fibrillation

Risk Factors of Galanaud et al for Post-Thrombotic Syndrome (PTS) Following a First Episode of Deep Vein Thrombosis

Acquired von Willebrand's Disease Associated with High Wall Shear Flow Rates

Risk Factors of Ahlbrecht et al for Venous Thromboembolism in a Patient with Cancer

Risk Factors of Caruso et al for Thromboembolism in Children with Acute Lymphoblastic Leukemia (ALL)

International Prognostic Score of Thrombosis in Essential Thrombocythemia (IPSET-thrombosis) of Barbui et al

Risk Factors of Cosgriff et al for Severe Coagulopathy in a Trauma Patient Who Has Been Massively Transfused

Data on Coagulation Factors

Using Thromboelastography to Guide the Management of a Bleeding Patient

Criteria of Kashuk et al for Hypercoagulability in a Postoperative Patient Using Rapid Thromboelastography

Recommendations of Stasi and Provan for Managing a Patient with Immune Thrombocytopenic Purpura

Risk Score of Atchison et al Hospital-Associated Venous Thromboembolism in a Noncritically-Ill Pediatric Patient

Risk of Deep Vein Thrombosis and Pulmonary Embolism in Chinese Patients with Sjogren?s Syndrome

Indications for Testing a Patient for the Factor V HR2 Haplotype

Model of Iannuzzi et al for Predicting Postdischarge Venous Thromboembolism

Model of Ruiz-Gimenez et al for Major Bleeding in a Patient Receiving Anticoagulation for an Acute Venous Thromboembolism (RIETE Score)

Antiphospholipid Score of Otomo et al

Indications of Lahey et al for a Laboratory Evaluation for Hypercoagulation for a Patient with Central Retinal Vein Occlusion (CRVO)

Score of Sivula et al for Disseminated Intravascular Coagulation (DIC) in the a Critically-Ill Patient

Predictors of Hagemo et al for Hypofibrinogenemia in an Adult Trauma Patient

Acquired Glanzmann?s Thrombasthenia

Differential Diagnosis of Thrombocytopenia in the Intensive Care Unit (ICU)

Clinical Prediction Score of Constans et al for Upper Extremity Deep Vein Thrombosis (UEDVT)

Clinical Prediction Score of Constans et al for Lower Limb Deep Vein Thrombosis in a Symptomatic Hospitalized Patient (Saint-Andre Hospital Score)

NAVAL Score of de Bastos et al for Predicting the Risk of Hospital-Acquired Venous Thrombosis

Indications of Hill et al to Screen a Patient with Thrombosis for Paroxysmal Nocturnal Hemoglobinuria (PNH)

Clinical Features of Thrombosis in Paroxysmal Nocturnal Hemoglobinuria (PNH)

Indications of Hall et al for Prophylactic Anticoagulation in a Patient with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Prognostic Score of Trujillo-Santos et al for an Outpatient with Acute Deep Vein Thrombosis (DVT) in the Lower Extremity

Prognostic Score of Rosa-Salazar et al for an Outpatient with Acute Deep Vein Thrombosis (DVT) in the Upper Extremity

Predictive Score of Nieto et al for Fatal Bleeding During Anticoagulant Therapy for Venous Thromboembolism

Decision Tree of Hong et al for a Patient with Microangiopathic Hemolytic Anemia and Possible Thrombotic Thrombocytopenic Purpura

Thrombotic Thrombocytopenic Purpura (TTP) Following Exposure to Amphetamine, Methamphetamine or Ecstasy

Thrombotic Thrombocytopenic Purpura (TTP) Associated with Thienopyridine (Clopidogrel, Prasugrel, Ticlopidine) Therapy

Pseudo-Thrombotic Thrombocytopenic Purpura (Pseudo-TTP) in a Patient with Vitamin B12 Deficiency (Pseudo-Thrombotic Microangiopathy)

The Global Anti-Phospholipid Syndrome Score (GAPSS) of Sciascia et al

Criteria of Asakura for the Enhanced Fibrinolytic Type of Disseminated Intravascular Coagulation (DIC)

Intensive Care After Thrombolysis (ICAT) Score of Faigle et al for a Patient with Stroke

SEDAN Score of Strbian et al for Predicting Symptomatic Intracranial Hemorrhage after Stroke Thrombolysis

Hemorrhage After Thrombolysis (HAT) Score of Lou et al for Predicting the Risk of Intracerebral Hemorrhage (ICH) in a Patient with Ischemic Stroke

GRASPS Score of Menon et al for Predicting Symptomatic Intracranial Hemorrhage after Stroke Thrombolysis

Risk Score of Cucchiara et al for Predicting the Risk of Intracerebral Hemorrhage (ICH) in a Patient with Ischemic Stroke

Stroke Prognostication Using Age and NIHSS (SPAN) Index for a Patient Undergoing Intravenous Thrombolysis for Ischemic Stroke

DIC, Thrombosis and Thrombohemorrhage in Acute Promyelocytic Leukemia (APML)

HERDOO2 Score of Rodger et al for Discontinuing Oral Anticoagulant Therapy in a Woman with an Unprovoked Venous Thromboemolism

Deep Vein Thrombosis (DVT) Associated with May-Thurner Syndrome (MTS, Iliac Vein Compression)

I-DVT and Adjusted I-DVT Scores of Dronkers et al for a Patient with Acute Deep Vein Thrombosis

ORBIT Bleeding Score of O'Brien et al for Bleeding Risk in Atrial Fibrillation

ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Score of Fang et al

Risk Factors of Kearon et al for Warfarin-Associated Hemorrhage

Age, Biomarkers, Clinical History (ABC) Bleeding Risk Score of Hijazi et al for a Patient with Atrial Fibrillation

Plasmic Score of Bendapudi et al for Identifying a Patient with Thrombotic Thrombocytopenic Purpura (TTP)

Algorithm of Williams et al for the Diagnosis of Microangiopathic Hemolytic Anemia (MAHA) Associated with Thrombocytopenic Purpura (TTP) or Atypical Hemolytic Uremic Syndrome (AHUS)

Algorithm of Williams et al for the Diagnosis of Microangiopathic Anemia (MAHA) Associated with Typical Hemolytic Uremic Syndrome (HUS)

Mortality in TTP Score (MITS) of Goel et al for a Patient with Thrombotic Thrombocytopenic Purpura (TTP)

Hypercoagulability Associated with Hereditary Stomatocytosis

Safe Implementation of Treatments in Stroke (SITS) Symptomatic Intracerebral Hemorrhage Risk Score of Mazya et al

Revised IPSET-Thrombosis (International Prognosis Score of Thrombosis for Essential Thrombocythemia - Thrombosis) of Barbui et al

Score of Koopman et al for Predicting Outcome for a Patient with Cerebral Venous Thrombosis (CVT)

Score of Ferro et al for Predicting Outcome for a Patient with Cerebral Vein and Dural Sinus Thrombosis

Platelet Count and the Prognosis of a Patient in the Intensive Care Unit (ICU)

Risk Factors of Wang et al for Venous Thromboembolism in a Patient Undergoing Spine Surgery

Venous Thrombosis in a Patient with Sickle Cell Disease

Acquired Risk Factors of Pannucci et al for Venous Thromboembolism After Thermal Burn Injury

Score of Pannucci et al for Risk of Venous Thromboembolism in a Burn Patient on Admission

Risk Score of Pannucci et al for Venous Thromboembolism Following Ventral Hernia Repair

Risk Score of Pannucci et al for 90-Day Postsurgical Venous Thromboembolism

TIMI-AF Score of Fanola et al for Predicting Risk of an Adverse Event in a Patient with Atrial Fibrillation

Coagulapathy of Severe Trauma (COAST) Score of Mitra et al

Prehospital Prediction Model for Acute Traumatic Coagulopathy (PACT) of Peltan et al

Thrombosis in a Patient with Eosinophilia

I-DVT Score of Dronkers et al for the Diagnosis of Acute Deep Vein Thrombosis (DVT)

Risk Factors of Baelum et al for Venous Thromboembolism (VTE) in a Patient with Thrombocytopenia

Score of Sermsathanasawadi et al for the Diagnosis of Lower Limb Deep Vein Thrombosis (DVT)

Criteria of Rast et al for Differentiating Deep Vein Thrombosis from Lower Limb Erysipelas in the Lower Limb

Risk Factors of Sivaslioglu et al for Thrombosis in Pediatric Patients with Acute Lymphoblastic Leukemia (ALL)

Clinical Score of Pomero et al for the Diagnosis of Deep Vein Thrombosis in a Patient with Superficial Vein Thrombosis (ICARO Score)

Risk Factors of Alkim et al for Deep Vein Thrombosis in a Patient with Inflammatory Bowel Disease (IBD)

Drug-Induced Venous Thromboembolism (VTE)

Neurological Syndrome Associated with Shiga-Toxin Producing E. coli (STEC) with Hemolytic Uremia Syndrome (Neuro-STEC)

Score of Rose et al for Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndrome (TTP/HUS)

Model of Benhamou et al for Predicting Mortality in a Patient with Acquired ADAMTS13-Deficient Idiopathic Thrombotic Thrombocytopenia Purpura (TTP)

Score of Coppo et al for Severe Acquired ADAMTS12 Deficiency and Thrombotic Microangiopathy (TMA, French TMA Diagnostic Score)

Complete Response, Relapse and Flare-Up of a Thrombotic Thrombocytopenic Purpura (TTP)

Criteria of the Korean Society for Thrombosis and Hemostasis (KSTH) for Overt DIC

Revised Japanese Association of Acute Medicine (R-JAAM) Score for Disseminated Intravascular Coagulation (DIC)

Criteria of the Japanese Society of Thrombosis and Hemostasis (JSTH) for Disseminated Intravascular Coagulation (DIC): Initial Triage

Criteria of the Japanese Society of Thrombosis and Hemostasis (JSTH) for Disseminated Intravascular Coagulation (DIC): Hematopoietic Disorder

Criteria of the Japanese Society of Thrombosis and Hemostasis (JSTH) for Disseminated Intravascular Coagulation (DIC): Infectious Disease

Criteria of the Japanese Society of Thrombosis and Hemostasis (JSTH) for Disseminated Intravascular Coagulation (DIC): Basic Type

Conditions Associated with Disseminated Intravascular Coagulation (DIC)

Modified ISTH Criteria of Clark for Disseminated Intravascular Coagulation (DIC During Pregnancy

Immune Thrombocytopenic Purpura (ITP) Bleeding Scale (IBLS) of Page et al

Risk Factors of Melboucy-Belkhir et al for Intracranial Hemorrhage in a Patient with Immune Thrombocytopenic Purpura (ITP)

Risk Factors of Webert et al for Bleeding in a Thrombocytopenic Patient with Acute Myeloid Leukemia (AML)

INR-Based Criteria of Peltan et al for Acute Traumatic Coagulopathy

4-Group Classification of Kawashima et al for Postoperative Bleeding After Cardiopulmonary Bypass Based on Fibrinogen and ROTEM (Fuji-san Classification)

IMPROVE Bleeding Risk Score for an Inpatient on a Medical Service

Azathioprine-Associated and 6-Mercaptuopruine-Associated Warfarin Resistance

Risk Factors of Kim et al for Venous Thromboembolism (VTE) in a Patient with Chronic Obstructive Pulmonary Disease (COPD)

Risk Factors of Chopra et al for Deep Vein Thrombosis Associated with a Peripherally-Inserted Central Catheter (PICC)

Risk Factors of Emuakhagbon et al for Deep Vein Thrombosis Following Liver Transplantation

Risk Factors of Faller et al for Mortality in an Older Adult with Acute Venous Thromboembolism

Risk Factors of Michetti et al for Deep Vein Thrombosis (DVT) During Acute Inpatient Rehabilitation Following Trauma

Risk Factors for Deep Vein Thrombosis Following Splenectomy

Risk Factors of Johnseon et al for Venous Thromboembolism in a Patient with System Sclerosis (Scleroderma)

Differential Diagnosis of Recurrent Deep Vein Thrombosis (DVT)

Diagnostic Approach of Trachil for Recurrent Deep Vein Thrombosis (DVT)

Splanchnic Vein Thrombosis

Renal Vein Thrombosis

Ovarian Vein Thrombosis

Atypical Hemolytic Uremic Syndrome (HUS) Associated with Factor H Autoantibodies (DEAP-HUS)

Hypercoagulability Associated with Cushing's Syndrome

Differential Diagnosis of Kobayashi Obstetrical Disseminated Intravascular Coagulation (DIC)

Obstetrical Disseminated Intravascular Coagulation (DIC) Score of Kobayashi: Underlying Disease Subscore

Obstetrical Disseminated Intravascular Coagulation (DIC) Score of Kobayashi: Subscore for Clinical Symptoms

Obstetrical Disseminated Intravascular Coagulation (DIC) Score of Kobayashi: Laboratory Subscore

Obstetrical Disseminated Intravascular Coagulation (DIC) Score of Kobayashi: Summary Score

Obstetrical Disseminated Intravascular Coagulation (DIC) Efficacy Score of Kobayashi: Laboratory Subscore

Obstetrical Disseminated Intravascular Coagulation (DIC) Efficacy Score of Kobayashi

Hazards of Nonsteroidal Anti-Inflammatory Drugs (NSAIDS) for a Patient Taking an Oral Anticoagulant for Atrial Fibrillation

Secondary Causes of Immune Thrombocytopenic Purpura (ITP)

Risk Factors of Andriani et al for Thrombosis in a Patient with Essential Thrombocythemia

Nomogram of Pabinger et al for Predicting Venous Thromboembolism in a Patient with Cancer

Risk Factors of Ihaddadene for Occult Malignancy in a Patient with a First Unprovoked Venous Thromboembolism (VTE)

COMPASS Cancer-Associated Thrombosis (CAT) Score of Gerotziafas et al

Coagulopathy Following Hepatic Resection

Trauma Induced Coagulopathy Clinical Score (TICCS) of Tonglet et al

Risk Factors of Lim et al for Failure of Anticoagulant Thromboprophylaxis in ICU Patients

Score of Pannucci et al for Predicting the Risk of Venous Thromboembolism After Outpatient Surgery

Score of Finks et al for Venous Thromboembolism After Bariatric Surgery

Predictors of Wakabayashi et al for the Presence of Deep Vein Thrombosis (DVT) in a Patient Prior to Total Hip Arthroplasty

Risk Factors of Wang for Venous Thromboembolism in a Hospitalized Patient Receiving Thromboprophylaxis

Criteria of Kelkar et al for Synthetic Cannabinoid-Associated Coagulopathy

Laboratory Detection of Poisoning with a Coumarin or Indandione Compound (Vitamin K Antagonist)

Protecht Score of Verso et al for Risk of Venous Thromboembolism in a Cancer Patient

CONKO Score of Pelzer et al for Risk of Venous Thromboembolism in a Cancer Patient

Differential Diagnosis of Hypofibrinogenemia

Prehospital Predictors of David et al for Coagulopathy in a Trauma Patient

Differential Diagnosis of Elevated Fibrin Degradation Products (D-Dimer, Fibrin Split Products)

Idarucizumab (Praxbind) for Reversal of Dabigatran (Pradaxa)

Andexanet Alfa (Andexxa) for Reversal of Anticoagulation with Apixaban and Rivaroxaban

Thrombosis Associated with Thrombocytosis and/or Erythrocytosis

Deep Vein Thrombosis Associated with Hereditary Hemorrhagic Telangiectasia

LEFt Clinical Decision Rule for Deep Vein Thrombosis Associated with Pregnancy

Risk Score of Arlikar et al for Hospital-Associated Venous Thromboembolism (HA-VTE) for a Critically-Ill Pediatric Patient

Risk Factors of Zhang et al for Upper Extremity Deep Vein Thrombosis (UEDVT) Associated with a Peripherally-Inserted Central Catheter (PICC) in a Patient with Cancer

SWEDEHEART Score of Simonsson et al for Major In-Hospital Bleeding After Acute Myocardial Infarction

S2TOP BLEED Score for Patients Taking Antiplatelet Drugs for Noncardioembolic Stroke

ESSENCE Criteria for Bleeding Severity Associated with Heparin Therapy

CURRENT-OASIS 7 Definition of Bleeding Severity

PLATO Definitions for Bleeding Severity

Sepsis-Induced Coagulopathy (SIC)

SAMe-TT2R2 Score for Predicting INR Control During Anticoagulation with a Vitamin K Antagonist

Clinical Prediction Model of Rabinovich et al for Postthrombotic Syndrome (SOX-PTS Score)

Clinical Prediction Rule of Louzada et al for Recurrent Thromboembolism in a Patient with Cancer-Associated Venous Thromboembolism (Ottawa Thromboembolism Rule)

Clinical Prediction Model of Dreijer et al for an Elevated INR in a Hospitalized Patient Receiving a Vitamin K Antagonist

Method of Poller et al for Rapid Derivation of the International Sensitivity Index (ISI) for a Coagulometer

Possible Causes of an Erroneous International Normalized Ratio (INR)

Risk Factors of Liabeuf et al for Bleeding in a Hospitalized Patient with an Elevated INR Associated with Vitamin K Antagonist Therapy

Deep Vein Thrombosis and Pulmonary Emboli in a Patient with Pancreatitis

DASH Score of Tosetto et al for Unprovoked Venous Thromboembolism

Clinical Model of Wells et al for Deep Vein Thrombosis

Thrombosis Risk Factor Assessment of Caprini et al

Prediction Model of Constans et al for Lower Limb Deep Vein Thrombosis in an Outpatient

Revised Criteria of Wells et al for Evaluating a Patient with Suspected Deep Vein Thrombosis

Clinical Thrombosis Risk Score of Chopard et al for an Acutely-Ill Medical Patient

International Society of Thrombosis and Hemostasis (ISTH) Criteria for Major Bleeding

Criteria of Kaatz et al for Nonmajor Bleeding in an Anticoagulated Patient

Identifying an Older Adult at Low Risk for Major Bleeding During Prolonged Oral Anticoagulation Therapy Based on the Study of Gomez-Cuervo et al

ACTION Registry Model of Mathews et al for In-Hospital Bleeding During Acute Myocardial Infarction Care

Risk Factors of Pishko et al for Major Bleeding in a Patient with Suspected Heparin-Induced Thrombocytopenia (HIT)

4T Score for Heparin-Induced Thrombocytopenia (HIT)

Score of Lillo-Le Louet et al for Heparin-Induced Thrombocytopenia After Cardiopulmonary Bypass

HIT Expert Probability (HEP) Score of Cuker et al for Heparin-Induced Thrombocytopenia

Risk Factors for Severe Complications in a Patient with Heparin-Induced Thrombocytopenia (HIT)

Model of Brass et al for Predicting Intracranial Hemorrhage After Thrombolytic Therapy for Acute Myocardial Infarction

Risk Factors of Piel-Julian et al for Severe Bleeding in an Adult with Newly-Diagnosed Immune Thrombocytopenia

Criteria of Ginsberg et al for the Postthrombotic Syndrome (PTS)

Bleeding Score of Rodeghiero et al

Risk Score of Bihari et al for Coagulopathic Bleeding in Decompensated Cirrhosis and Acute-on-Chronic Liver Failure (ACLF)

Predictors of Spiezia et al for Postoperative Bleeding in a Pediatric Patient Undergoing Cardiopulmonary Bypass

Model of Heldner et al for the Diagnosis of Cerebral Venous Thrombosis

Delayed Cerebral Thrombosis Following Acute Bacterial Meningitis

Tissue Plasminogen Activator-Associated Fibrinolysis During Orthotopic Liver Transplantation

Quinine-Induced Thrombocytopenic Purpura (Cocktail Purpura)

Criteria of Lee et al for Post-Operative Coagulopathy

Grades of Lewis et al for Intraoperative Bleeding Severity (Validated Intraoperative Bleeding Scale, VIBe Scale)

Thalassemia-Related Thrombosis Risk Scoring System (TRT-RSS) of Taher et al

Risk of Thrombosis Associated with the Nephrotic Syndrome

Quick Risk Assessment Profile (qRAP) of Tachino et al to Predict Post-Traumatic Venous Thromboembolism

ICU-Venous Thromboembolism Score of Viarasilpa et al

Risk Calculator of Schlick et al for Post-Discharge Venous Thromboembolism Following Hepatectomy for Malignancy

Risk Calculator of Schlick et al for Post-Discharge Venous Thromboembolism Following Surgery for Inflammatory Bowel Disease

B2LEED3S Score for Intracranial Hemorrhage Associated with Antiplatelet Therapy

Model of Li for In-Hospital Bleeding in a Patient with Acute ST-Segment Elevation Myocardial Infarction (STEMI)

Predictive Score of Gui et al for Early Identification of Refractory Thrombotic Thrombocytopenic Purpura (TTP)

Prediction Model of Schmidt et al for Predicting Transient versus Persistent Childhood Immune Thrombocytopenia

Risk Score of Li et al for Predicting Venous Thromboembolism in a Patient with Lung Cancer

M.D. Anderson Cancer Center Cancer-Associated Venous Thromboembolism (CAT) Score

Thrombogyn Score for Predicting of Venous Thromboembolism in a Patient with Gynecologic Cancer

Model of Liu et al for Intravenous Catheter-Related Thrombosis in a Patient with Cancer

Clinical Prediction Rule of Al-Ani et al for Venous Thromboembolism in a Patient with Acute Leukemia

BASIC (Bleeding Assessment Scale in Critically Ill Children) Criteria for Bleeding Severity

IMPEDE VTE Score of Sanfilippo et al for Thrombosis in a Patient with Multiple Myeloma

Model of Jaffray et al for Pediatric Hospital-Acquired Thrombosis (HA-VTE RAM)

Model of Sultan et al for Prediction of Venous Thromboembolism in a Postpartum Woman

Risk Factors of Blondon et al for Venous Thromboembolism Following Delivery

Predictive Model of Kelly et al for Venous Thromboembolism After Fusion of the Thoracolumbar Spine

Criteria of Franco et al for Major Anticoagulant-Associated Bleeding

BleeMACS Score of Raposeiras-Roubin et al for Post-Discharge Bleeding Risk in a Patient Receiving Dual Antiplatelet Therapy (DAPT)

Intra-Abdominal Complications of the Antiphospholipid Syndrome (aPL)

Computerized Risk Scoring System of Gallo et al for Heparin-Induced Thrombocytopenia Risk (HIT-CR)

Autoimmune Heparin-Induced Thrombocytopenia (aHIT)

Criteria of Lyons et al for Sepsis-Associated Coagulopathy (SAC)

Clinical Findings of Moulis et al for Newly Diagnosed Immune Thrombocytopenia (ITP) in an Adult

Predictors of Engel et al for Postthrombotic Syndrome in a Pediatric Patient with Thrombosis

Screening for Occult Malignancy in a Patient with Idiopathic Venous Thromboembolism (SOME) Model of Ihaddadene et al

Risk Prediction Score of Jara-Palomares et al for Occult Cancer in a Patient with Venous Thromboembolism (VTE RIETE Score)

Scores of Ferreyro et al for Predicting Cancer or Death Within 1 Year of a Venous Thromboembolism (VTE)

Bone Wax as a Hemostatic Agent

DAPT (Dual Antiplatelet Therapy) Score of Liu et al for a Patient with Acute Cerebral Infarction (ACI)

L-TRiP (cast) Score of Nemeth et al for Venous Thrombosis Risk After Cast Immobilization of the Lower Extremity

Risk Factors of Barco e al for Thromboembolic Events and Major Bleeding in a Patient Receiving Home Parenteral Nutrition

CHAT Score of Gu et al for Predicting In-Hospital Venous Thrombosis After Hernia Surgery

Superior Vena Cava Syndrome (SVCS) Due to Venous Thrombosis

Risk Factors of Sochala et al for Venous Thromboembolism in a Patient with Myotonic Dystrophy

Risk of Venous Thrombosis Based on eGFR and Albuminuria

Risk Factors of Zhou et al for Early Postpartum Venous Thromboembolism

Plymouth VTE Risk Score

Bleeding Risk Score of Adam et al for a Patient with Atrial Fibrillation on Oral Anticoagulants

Scores of Rutherford et al for Bleeding Risk in a Patient Receiving a Non-Vitamin K Oral Anticoagulant (NOAC): Full Model

Scores of Rutherford et al for Bleeding Risk in a Patient Receiving a Non-Vitamin K Oral Anticoagulant (NOAC): Short Model (ABH Score)

Antiphospholipid Antibodies in a Patient with Sickle Cell Disease (SCD)

Score of Erdur et al for Risk of Thrombolysis-Associated Intracranial Hemorrhage in a Patient with an Acute Ischemic Stroke (Risk of sICH Score, RICH Score)

TURN and TURNP Scores for Prediction of Symptomatic Intracerebral Hemorrhage After Intravenous Thrombolysis

BACS Score of Jara-Palomares et al for Predicting Major Bleeding Following Thrombolysis for Acute Pulmonary Embolism

Risk Score of Zwart et al for Triple Antithrombotic Therapy in a Patient with Atrial Fibrillation Who Undergoes Percutaneous Coronary Intervention (PCI)

ONKOTEV Score of Cella et al for Predicting Venous Thromboembolism in a Cancer Patient

ThroLy Score of Antic et al for Prediction of Venous Thromboembolism in a Patient with Malignant Lymphoma

CoVID-TE Risk Assessment Model for Venous Thromboembolism in a Hospitalized Patient with Cancer and COVID-19

Predictors of Abdel-Razeq et al for Venous Thromboembolism in a Patient with Testicular Germ Cell Tumor

Bentracimab for Immediate Reversal of Ticagrelor

Peripartum (Postpartum, Puerperal) Cerebral Arterial or Venous Thrombosis

Nomogram of Feng and Li for Predicting Lower Extremity Deep Vein Thrombosis in a Patient with Acute Carbon Monoxide Poisoning

Risk Factors of Eck et al for Venous Thromboembolism in a Critically Ill Patient

Nomogram of Li et al for Predicting Lower Extremity Deep Vein Thrombosis (DVT) in a Neurointensive Care Unit Patient

Nomogram of Pan et al for Lower Extremity Deep Vein Thrombosis in a Patient After an Acute Stroke

Ultrasound Criteria of Maufus et al for Recurrent Deep Vein Thrombosis (DVT)

Predictors of Tran et al for Venous Thromboembolism in a Patient in the Intensive Care Unit (ICU)

NOAC Bleeding Prediction (NBP) Score for Major Bleeding in a Patient Being Treated for Atrial Fibrillation

Disseminated Thromboembolic Storm in COVID-19

Risk Score of Atiq et al for Future Bleeding in a Patient with von Willebrand Disease (vWD)

Differential Diagnosis of Despotis et al for Hemostatic Abnormalities Associated with Cardiopulmonary Bypass (CPB)

Coagulopathy in a Patient with Mechanically Assisted Circulation (MAC)

Model of Feng and Li for Deep Vein Thrombosis in a Patient with Carbon Monoxide Poisoning

Children's Hospital Acquired Thrombosis (CHAT) Risk Assessment Model for Hospital-Acquired Venous Thromboembolism in a Critically Ill Child

Intracerebral Hemorrhage Deep Vein Thrombosis (ICH-DVT) Score of Ji et al

Thrombosis Associated with Diabetic Ketoacidosis (KA) or Hyperosmolar Hyperglycemic State (HHS)

Risk Factors of Moore et al for Venous Thromboembolism (VTE) After Adrenalectomy for an Adrenal Cortical Neoplasm

Hyperviscosity-Associated Thrombosis

PADIS-PE Score of Tromeur et al for Recurrent Venous Thromboembolism After Unprovoked Pulmonary Embolism

Bleeding Risk Prediction Score of Phetroong et al for a Patient on Long-Term Warfarin Therapy for Heart Valve Disease (HEARTS-60+3 Score)

Score of Alhousseini et al for Non-Overt Disseminated Intravascular Coagulation (DIC) in Pregnancy

Risk Factors of Go et al for Disseminated Intravascular Coagulation (DIC) in a Neonate

Score of the JSOGNH for Disseminated Intravascular Coagulation (DIC) in a Neonate

Risk Factors of Maze et al for Intracranial Hemorrhage in an Adult with Acute Leukemia

HIGH-2-LOW Score of Martens et al for Predicting Venous Thromboembolism in Allogeneic Transplant Patients After Platelet Engraftment

Predictors of Wagner et al for Postoperative Venous Thromboembolism in a Woman with Uterine Cancer

Risk Factors of Montesinos et al for Thrombosis in a Patient with Acute Promyelocytic Leukemia (APML)

Risk of Venous Thromboembolism in a Woman Receiving Tamoxifen in the Peri-Operative Period

Pharyngolaryngeal Hematoma in Hemophilia

Equation of Hohlfelder et al for Predicting Change in INR with Change in Bivalirudin Infusion

Predictors of a Large Change in INR After Stopping an Infusion of Bivalirudin

IMPROVEDD Score for Predicting Venous Thromboembolism

Nomogram of Yan et al for Predicting Risk of Preoperative Deep Vein Thrombosis Progression After Elective Spine Surgery

Predictors of Wang et al for Preoperative Deep Vein Thrombosis (DVT) in a Hip Fracture Patient

Risk Score of Shekarchian et al for Ileofemoral Deep Vein Thrombosis (IFDVT)

Model of Zakai et al for Venous Thrombosis Risk in a Medical Inpatient (MITH Score)

Alfalfa-DOAC-GIB Score of Lv et al for Major Gastrointestinal Bleeding in a Patient Receiving a Direct Oral Anticoagulant (DOAC)

Score of Cuschieri et al for Acute Gastrointestinal Bleeding in a Patient Treated with Clopidogrel

Risk Factors of Rydberg et al for Severe Bleeding in a Patient Receiving Warfarin

Nomogram of Chen et al for Predicting Major Bleeding in a Patient with Atrial Fibrillation Receiving a Direct Oral Anticoagulant (DOAC, Alfalfa MB Score)

Score of Shimomura et al for Acute Gastrointestinal Bleeding in a Patient Taking an Oral Anticoagulant

OAC3-PAD Score of Behrendt et al for Predicting Major Bleeding Events in a Patient with Peripheral Artery Disease (PAD)

The Utah Bleeding Risk Score (UBRS) of Yin et al for Predicting Gastrointestinal Bleeding in a Patient with a Left Ventricular Assist Device (LVAD)

Risk Score of Goriki et al for Bleeding in a Hospitalized Patient with an Acute Myocardial Infarction

VTE-BLEED Risk Score of Klok et al for Prediction of Bleeding in a Patient Receiving Anticoagulation Therapy for Venous Thromboembolism

Risk Score of Martinez et al for Predicting Bleeding in a Patient Treated with a Vitamin K Antagonist

Thrombotic Microangiopathy Score (TMA) of Yoo et al

Thrombocytopenia-Associated Multiple Organ Failure (TAMOF)

Immune Thrombocytopenic Purpura (ITP) Secondary to Sarcoidosis

Thrombosis in a Patient with Immune Thrombocytopenic Purpura (ITP)

Score of Edslev et al for Predicting Brief and Uneventful Course for a Child with Idiopathic Thrombocytopenic Purpura (ITP, NOPHO Score)

Score of Donato et al for a Child with Idiopathic Thrombocytopenic Purpura (ITP)

Criteria of Rodeghiero et al for Refractory Immune Thrombocytopenic Purpura (ITP)

Criteria of Rodeghiero et al for the Therapeutic Response of a Patient with Immune Thrombocytopenic Purpura (ITP)

CAT-BLEED Score of de Winter et al for the Risk of a Patient with Cancer-Associated Thrombosis (CAT) Bleeding During Anticoagulation Therapy

Hypothermic Coagulopathy

Senile Purpura

NIH Grading of Oral Changes in Chronic Graft-versus-Host Disease (cGVHD)

Nomogram of Lin et al for Predicting Risk of Venous Thromboembolism for a Patient Receiving Invasive Mechanical Ventilation

Indications of Stevens et al for Anticoagulation of Distal Deep Vein Thrombosis (dDVT)

Indications of Stevens et al for Anticoagulation of a Patient with an Isolated Subsegmental Pulmonary Embolism (ISSPE)

Indications of Stevens et al for Anticoagulation of a Patient with Superficial Vein Thrombosis (SVT)

Nomogram of Wu and Cheng for Predicting Postoperative Deep Vein Thrombosis Following Repair of a Femoral Fracture

Kagoshima-DVT Score (KDS)

CREDO-Kyoto Scores of Natsuaki for Events After Percutaneous Coronary Intervention (PCI): Thrombotic Risk Score

CREDO-Kyoto Scores of Natsuaki for Events After Percutaneous Coronary Intervention (PCI): Bleeding Risk Score

Laboratory Criteria of Nishimura et al to Distinguish TTP from Sepsis-Related DIC

Bone Cement Hypercoagulation Syndrome

Supra-Blan2t Score of Jin et al for Predicting Outcome After Intravenous Thrombolysis for Acute Ischemic Stroke

Predictive Model of Ma et al for Hemorrhagic Transformation After Thrombolysis for Ischemic Stroke

BIWACO Score of Takeda et al for a Patient Developing Atrial Fibrillation After Percutaneous Coronary Intervention (PCI)

Prediction Score of Ishii et al for Outcome in a Patient with Atrial Fibrillation and Stable Coronary Artery Disease

Predict ITP Tool of Li et al for Predicting Immune Thrombocytopenia

Prediction of Fibrinogen Concentration After Cardiac Surgery with Cardiopulmonary Bypass

Nomogram of You et al for Predicting Thrombotic Complications in a Pediatric Liver Transplant Recipient

Cerebral Venous Thrombosis (CVT) Outcome Score of Li et al for Chinese Patients

Model of Qin et al for Predicting Linezolid-Induced Thrombocytopenia in an Older Adult

Spontaneous Hemorrhage Associated with Neurofibromatosis (von Recklinghausen's Disease) Type 1